View older revisions Content changed at 2017-12-14, 1396/09/23

Protocol summary

Study aim
Objectives: investigating the effects of a multisite transcranial random noise stimulation (tRNS) on tinnitus loudness, distress, MMN response and electroencephalography in chronic tinnitus subjects.
Design
Design: it is an interventional, one phase, and randomized, single blinded study. We have two groups: the intervention group in which we will apply the (high frequency) hf-tRNS over the right DLPFC (Dorso Lateral Prefrontal Cortex) followed by (low frequency) lf-tRNS over the auditory cortex in one session. And the control group in which we will apply the lf-tRNS over the auditory cortex only. Each patient in these two groups will take a placebo (Sham stimulation) session before the active tRNS session. There is randomization in allocating patients in groups, but they will take the two treatment stages (placebo & active) without randomization. Patients will be randomly organized into the two groups, but they will take the two treatment stages (placebo & active) without randomization i.e in all cases we will begin with the Sham stimulation. The way of randomization is by drawing a number between 1-32 where numbers from 1 to 16 is referring to the intervention group while numbers from 17 to 32 is referring to the control group. The randomization will be done by using Matlab.
Settings and conduct
Setting: After signing the consent form, Patients will be allocated randomly into two groups. In each group, each patient blindly will undertake both Sham and tRNS simulations beginning with the Sham one. Each patient will complete the VAS-L and VAS-A (Visual Analogue Scale) before and immediately after each session. In addition, EEG and MMN recording will be taken before and immediately after each session.
Participants/Inclusion and exclusion criteria
Participants: all patients with chronic nonpulsatile tinnitus (>6 months) can participate in this study with the following entry criteria: age between 20 and 50 years, the behavioral pure-tone audiometry threshold levels of ≤20 dBHL in octave frequencies of 250–2000 Hz and not more than 40 dBHL in frequencies of 4000 -8000 Hz, and the tinnitus intensity moderate to severe; not having a remarkable cognitive problems, a previous formal musical training, or a history of otological, neurological, mental diseases, head trauma, psychiatric disorders, seizure and finally not having a pacemaker or defibrillator.
Intervention groups
Our intervention is applying transcranial random noise electrical stimulation with two protocols: multisite (auditory and prefrontal), and the auditory cortex. The placebo intervention is given by using the Sham stimulation mode; the current is switched off automatically after a ramp-in of 10 seconds and the session will be given in the same mentioned protocols in active interventions concerning electrode arrays and the time of the session which lasts for 20 minutes.
Main outcome variables
Tinnitus related loudness, tinnitus related annoyance (distress), MMN amplitude & MMN area under curve, Mean frequency of EEG waves, EEG absolute & relative powers and the EEG activity in ROIs (region of interest) as main outcome measures. The tinnitus pitch as a secondary variable.

General information

Reason for update
Acronym
-
IRCT registration information
IRCT registration number: IRCT2017050724360N2
Registration date: 2017-06-30, 1396/04/09
Registration timing: prospective

Last update: 2017-12-14, 1396/09/23
Update count: 1
Registration date
2017-06-30, 1396/04/09
Registrant information
Name
Akram Pourbakht
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 21 2225 0541
Email address
pourbakht.a@iums.ac.ir
Recruitment status
Recruitment complete
Funding source
Vice chancellor for research, Iran University of Medical Sciences
Expected recruitment start date
2017-06-01, 1396/03/11
Expected recruitment end date
2017-10-31, 1396/08/09
Actual recruitment start date
2017-07-15, 1396/04/24
Actual recruitment end date
2017-10-28, 1396/08/06
Trial completion date
empty
Scientific title
The effect of a multisite transcranial random noise stimulation (tRNS) on tinnitus loudness, distress, mismatch negativity response (MMN) and electroencephalography (QEEG) in subjects with chronic tinnitus
Public title
The effect of electrical stimulation on treatment of chronic tinnitus
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Right-handedness Chronic nonpulsatile tinnitus (>6 months) Age between 20 and 50 years Normal external and middle ear function and appearance using otoscopy and tympanometry Behavioral pure-tone audiometry threshold levels of ≤20 dBHL in octave frequencies of 250–2000 Hz and not more than 40 dBHL in frequencies of 4000 -8000 Hz Moderate to severe tinnitus intensity (THI score over 38-76)
Exclusion criteria:
Remarkable cognitive problems (MMSE over 20); Previous formal musical training Depression and anxiety (HADS scores less than 11 from 21 for either depression and anxiety) A history of otological, neurological, mental diseases, head trauma, pregnancy, psychiatric disorders, dementia, seizure or any organic diseases that cause tinnitus; Having a pacemaker or defibrillator Taking specific medication that could modify the stimulation effect: (i.e., amine metabolism drugs: citalopram, sulpiride, and pergolide; amino acid metabolism drugs: lorazepam, rivastigmine. Moreover, voltage-sensitive channel blockers: carbamazepine and flunarizine).
Age
From 20 years old to 60 years old
Gender
Both
Phase
1
Groups that have been masked
  • Participant
Sample size
Target sample size: 32
Actual sample size reached: 33
Randomization (investigator's opinion)
Randomized
Randomization description
Patients will be simply randomized into two groups, but they will take the two treatment stages (placebo & active) without randomization i.e in all cases we will begin with the Sham stimulation. The way of randomization is by drawing a number between 1-32 where numbers from 1 to 16 is referring to the intervention group while numbers from 17 to 32 is referring to the control group. The randomization will be done by computer using Matlab.
Blinding (investigator's opinion)
Single blinded
Blinding description
All participants have no information about kind of their treatment session (placebo or real). They also have no information about in which group they are participating. However, the researcher knows these details and he is the performer of the experiment.
Placebo
Used
Assignment
Parallel
Other design features
-

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics committee of Iran University of Medical Sciences
Street address
Milad Tower, Shiekh Fazlollah NouriShahid, Hemmat Highway
City
Tehran
Province
Tehran
Postal code
1449614535
Approval date
2017-04-22, 1396/02/02
Ethics committee reference number
IR.IUMS.REC 1395.9321667001

Health conditions studied

1

Description of health condition studied
tinnitus
ICD-10 code
H93.1
ICD-10 code description
Tinnitus

Primary outcomes

1

Description
Tinnitus related loudness
Timepoint
Immediately after the treatment session
Method of measurement
Visual Analogue Scale (VAS-L)

2

Description
Tinnitus related annoyance(distress)
Timepoint
Immediately after the treatment session
Method of measurement
Visual Analogue Scale (VAS-A)

3

Description
MMN amplitude
Timepoint
Immediately after the treatment session
Method of measurement
MMN software

4

Description
MMN area under curve
Timepoint
Immediately after the treatment session
Method of measurement
MMN software

5

Description
Mean frequency of EEG waves
Timepoint
Immediately after the treatment session
Method of measurement
Mean frequency of EEG waves

6

Description
EEG absolute powers
Timepoint
Immediately after the treatment session
Method of measurement
EEG software

7

Description
EEG relative powers
Timepoint
Immediately after the treatment session
Method of measurement
EEG software

8

Description
EEG activity in ROIs (region of interest)
Timepoint
Immediately after the treatment session
Method of measurement
EEG software (sLORETA)

Secondary outcomes

1

Description
Tinnitus pitch
Timepoint
Before treatment
Method of measurement
Pitch matching

Intervention groups

1

Description
Control group: in this group the intervention is low frequency-tRNS with the same parameters used in the intervention group with one difference concerning the electrode array. In this concern the whole 20 minutes session will be applied over the auditory cortex (T3, T4). Before the active session the patient will take a sham stimulation session.
Category
Treatment - Devices

2

Description
Intervention group: Stimulation is delivered by a battery-driven electrical stimulator (NeuroStim2; Medinateb, Iran) through conductive rubber electrodes, placed in two saline-soaked sponges. In the stimulation mode “noise” there is a random level of current generated for every sample (sampling rate 1280 samples/s). The random numbers are normally distributed; the probability density function follows a bell-shaped curve. In the frequency spectrum all coefficients have a similar size (“white noise”). The noise signal contains all frequencies up to half of the sampling rate, i.e., a maximum of 640 Hz. In our experiment this frequency spectrum is separated into a low (0.1–100 Hz)-frequency which will be applied over the auditory cortex (AC-tRNS) for 10 minutes followed by the high (101–640 Hz)-frequency spectrum stimulation of the DLPFC (DLPFC-tRNS) for the following 10 minutes to have an active stimulation session of 20 minutes called the multisite one. Because of the statistical characteristics, the signal has no DC offset, provided that the offset is set to zero and the intensity of alternating current is 2.0 mA which, is initially increased in a ramp-like fashion over several seconds (30 s) until reaching 2.0 mA. In the AC-tRNS, the electrodes is placed over the left and right auditory cortices (T3, T4), while in the DLPFC-tRNS they will be placed over the right DLPFC (F4) and the left frontopolar cortex (FP1) as determined by the International 10/20 Electroencephalogram System. In the stimulation mode “sham” the current is switched off automatically after a ramp-in of 30 seconds. Each patient in the group will take a sham stimulation session before taking his/her active intervention without knowing which of them is placebo. The session will be given in the same mentioned protocols in active intervention concerning electrode arrays and the time of the session.
Category
Treatment - Devices

Recruitment centers

1

Recruitment center
Name of recruitment center
ENT and Head & Neck Research center, Iran University of Medical Sciences
Full name of responsible person
Samer Mohsen
Street address
Hazrat-e Rasool General Hospital, Niyayesh St., Satarkhan St., Tehran, Iran
City
Tehran
Province
Tehran
Postal code
1445613131
Phone
+98 21 6655 2828
Email
mohsen.s@tak.iums.ac.ir

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Dr Kazem Malakouti
Street address
Vice chancellor for research, Vice chancellor for International Affairs,Iran University of Medical Sciences, near Milad Tower, Shahid Hemmat Highway. Tehran
City
Tehran
Province
Tehran
Postal code
۱۴۴۹۶۱۴۵۳۵
Phone
+98 21 8670 2503
Email
research@iums.ac.ir
Web page address
http://vcr.iums.ac.ir
Grant name
-
Grant code / Reference number
-
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Iran University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Saeid Mahmoudian
Position
Assistant Professor
Latest degree
Ph.D.
Other areas of specialty/work
Neuroscience
Street address
Hazrat-e Rasool General Hospital, Niyayesh St., Satarkhan St., Tehran, Iran
City
Tehran
Province
Tehran
Postal code
1445613131
Phone
+98 21 6655 2828
Fax
Email
mahmoudian.s@iums.ac.ir
Web page address
http://www.ent-hns.org/links/neuroSci.php

Person responsible for scientific inquiries

Contact
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Akram Pourbakht
Position
Associate Professor
Latest degree
Ph.D.
Other areas of specialty/work
Audiology
Street address
Faculty of Rehabilitation, Madadkaran st., Shahnazari st., Madar sq., Mirdamad
City
Tehran
Province
Tehran
Postal code
13487 - 15459
Phone
+98 21 2225 0541
Fax
Email
pourbakht.a@iums.ac.ir
Web page address

Person responsible for updating data

Contact
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
samer Mohsen
Position
ENT specialist and PhD student
Latest degree
Specialist
Other areas of specialty/work
Audiology
Street address
Faculty of Rehabilitation, Madadkaran st., Shahnazari st., Madar sq., Mirdamad
City
Tehran
Province
Tehran
Postal code
13487 - 15459
Phone
+98 21 2225 0541
Fax
Email
mohsen.s@tak.iums.ac.ir
Web page address

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Loading...